share_log

FDA Rejection of MDMA Therapy Isn't End of Psychedelic-Drug Candidates -- Barrons.com

FDA Rejection of MDMA Therapy Isn't End of Psychedelic-Drug Candidates -- Barrons.com

美国食品药品监督局拒绝MDMA治疗并不代表迷幻药物候选药物的终结——巴伦财经网
Barron's ·  12:47

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发